The Impact of Upadacitinib versus Methotrexate or Adalimumab on Individual and Composite Disease Measures in Patients with Rheumatoid Arthritis

Van, Vollenhoven Ronald; Ostor, Andrew; Mysler, Eduardo; Damjanov, Nemanja S; Song, In-Ho; Song, Yanna; Suboticki, Jessica; Strand, Vibeke

Rezultati

eNauka > Results > The Impact of Upadacitinib versus Methotrexate or Adalimumab on Individual and Composite Disease Measures in Patients with Rheumatoid Arthritis

Title :	The Impact of Upadacitinib versus Methotrexate or Adalimumab on Individual and Composite Disease Measures in Patients with Rheumatoid Arthritis
Authors:	Van, Vollenhoven Ronald; Ostor, Andrew; Mysler, Eduardo; Damjanov, Nemanja S; Song, In-Ho; Song, Yanna; Suboticki, Jessica; Strand, Vibeke
Issue Date:	2019
Publication:	ARTHRITIS & RHEUMATOLOGY
ISSN:	2326-5191 Arthritis & Rheumatology Search Idenfier
Type:	Conference Paper
Collation:	vol. 71
WoS-ID:	000507466900524
URI:	https://enauka.gov.rs/handle/123456789/811528
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	Mp. category will be shown later

Pronađi DOI

Pronalaženje DOI u servisu CrossRef-u na osnovu meta-podataka u zapisu. Prikazaće se DOI (i metapodaci) čiji se podaci najviše poklapaju. OPREZ - to ne mora biti ta publikacija.

Google Scholar^TM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.